Control of Rheumatoid Arthritis by Oral Tolerance

Arthritis and Rheumatism

Volumn 44, Issue 9, 2001, Pages 1993-1997

  Choy, E H S ^a,c   Scott, D L ^a   Kingsley, G H ^a   Thomas, S ^a   Murphy, A G V ^b   Staines, N ^a   Panayi, G S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

ADULT; AGED; ANIMAL; ARTICLE; CATTLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TABLET; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANIMALS; ARTHRITIS, RHEUMATOID; CATTLE; COLLAGEN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; TABLETS; TREATMENT OUTCOME;

EID: 0035460223     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200109)44:9<1993::AID-ART347>3.0.CO;2-A     Document Type: Article

References (25)

1. Clague RB, Shaw MJ, Holt PJ. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann Rheum Dis 1980;39:201-6.
2. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146: 857-68.
3. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
4. Staines NA, Hardingham T, Smith M, Henderson B. Collagen-induced arthritis in the rat: modification of immune and arthritic responses by free collagen and immune anti-collagen antiserum. Immunology 1981;44:737-44.
5. Phadke K, Fouts R, Parrish JF. Collagen-induced and adjuvant-induced arthritis in rats: post-immunization treatment with collagen to suppress or abrogate the arthritic response. Arthritis Rheum 1984;27:797-806.
6. Thompson HS, Staines NA. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 1986;64:581-6.
7. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A 1986;83:7443-6.
8. Faria AM, Weiner HL. Oral tolerance: mechanisms and therapeutic applications. Adv Immunol 1999;73:153-264.
9. Yoshino S, Quattrocchi E, Weiner HL. Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen. Arthritis Rheum 1995;38:1092-6.
10. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Hafler DA, et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993;261:1727-30.
11. Sieper J, Kary S, Sörensen H, Alten R, Eggens U, Hüge W, et al. Oral type II collagen treatment in early rheumatoid arthritis: a double-blind, placebo-controlled, randomized trial. Arthritis Rheum 1996;39:41-51.
12. Barnett ML, Kremer JM, St. Clair EW, Clegg DO, Furst D, Weisman M, et al. Treatment of rheumatoid arthritis with oral type II collagen: results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 1998;41:290-7.
13. Paulus HE, Egger MJ, Ward JR, Williams HJ, and The Cooperative Systematic Studies of Rheumatic Diseases Group. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 1990;33:477-84.
14. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
17. Scott DL, Panayi GS, van Kiel PL, Smolen J, van de Putte LB. Disease activity in rheumatoid arthritis: preliminary report of the Consensus Study Group of the European Workshop for Rheumatology Research. Clin Exp Rheumatol 1992;10:521-5.
18. Van Gestel AM, Haagsma CJ, van Riel PLCM. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845-50.
19. Staines NA. Oral tolerance and collagen arthritis. Br J Rheumatol 1991;30:40-3.
20. McKown KM, Carbone LD, Kaplan SB, Aelion JA, Lohr KM, Cremer MA, et al. Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis. Arthritis Rheum 1999;42:1204-8.
21. Weiner HL, Friedman A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L, et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune disease by oral administration of autoantigens. Annu Rev Immunol 1994;12:809-37.
22. Morteau O. COX-2: promoting tolerance. Nat Med 1999;5:867-8.
23. Hauselmann HJ, Caravatti M, Seifert B, Wang K, Bruckner P, Stucki G, et al. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial. Br J Rheumatol 1998;37:1110-7.
24. Metzler B, Wraith DC. Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 1996;778:228-42.
25. Pierre P, Denis O, Bazin H, Mbongolo Mbella E, Vaerman JP. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit. Eur J Immunol 1992;22:3179-82.